The binding of low-affinity and high-affinity heparin to antithrombin. Fluorescence studies
- PMID: 710412
- DOI: 10.1111/j.1432-1033.1978.tb12567.x
The binding of low-affinity and high-affinity heparin to antithrombin. Fluorescence studies
Abstract
The interaction between antithrombin and two forms of heparin, differing in their affinity for the matrix-linked protein, has been studied by fluorescence. The binding of the high-affinity heparin fraction to antithrombin leads to activation of the inhibitor, allowing it to react more rapidly with a number of serine proteases of the coagulation cascade. The interaction with the low-affinity heparin fraction, however, has considerably less influence on this inhibition rate. The binding of either fraction to antithrombin was found to result in an increase of the tryptophan fluorescence of the protein. This increase was much larger for high-affinity heparin than for low-affinity heparin, suggesting a different mode of binding of the two fractions to the protein. The fluorescence enhancement caused by high-affinity heparin is consistent with a conformational change of antithrombin related to its activation. Only the fluorescence enhancement observed on the binding of high-affinity heparin was of a sufficient magnitude to allow quantitative studies. These showed high-affinity heparin to bind to antithrombin with a stoichiometry of about one and with a binding constant at physiological ionic strength of about 8 X 10(7) M-1. At higher ionic strengths, however, the affinity decreased markedly.
Similar articles
-
Binding to antithrombin of heparin fractions with different molecular weights.Biochem J. 1981 Feb 1;193(2):427-33. doi: 10.1042/bj1930427. Biochem J. 1981. PMID: 7305940 Free PMC article.
-
Influence of ionic strength and pH on the interaction between high-affinity heparin and antithrombin.Biochim Biophys Acta. 1981 Feb 5;672(3):227-38. doi: 10.1016/0304-4165(81)90289-0. Biochim Biophys Acta. 1981. PMID: 7213813
-
Conformational equilibrium of the reactive center loop of antithrombin examined by steady state and time-resolved fluorescence measurements: consequences for the mechanism of factor Xa inhibition by antithrombin-heparin complexes.Biochemistry. 2001 Jun 5;40(22):6680-7. doi: 10.1021/bi0029346. Biochemistry. 2001. PMID: 11380263
-
Antiangiogenic function of antithrombin is dependent on its conformational variation: implication for other serpins.Protein Pept Lett. 2013 Apr;20(4):403-11. Protein Pept Lett. 2013. PMID: 23016581 Review.
-
Role of heparin and heparinlike molecules in thrombosis and atherosclerosis.Fed Proc. 1985 Feb;44(2):404-9. Fed Proc. 1985. PMID: 3155697 Review.
Cited by
-
Elimination of glycosylation heterogeneity affecting heparin affinity of recombinant human antithrombin III by expression of a beta-like variant in baculovirus-infected insect cells.Biochem J. 1995 Aug 15;310 ( Pt 1)(Pt 1):323-30. doi: 10.1042/bj3100323. Biochem J. 1995. PMID: 7646463 Free PMC article.
-
Binding to antithrombin of heparin fractions with different molecular weights.Biochem J. 1981 Feb 1;193(2):427-33. doi: 10.1042/bj1930427. Biochem J. 1981. PMID: 7305940 Free PMC article.
-
Clinical pharmacokinetics of heparin.Clin Pharmacokinet. 1980 May-Jun;5(3):204-20. doi: 10.2165/00003088-198005030-00002. Clin Pharmacokinet. 1980. PMID: 6993082 Review.
-
Interaction of heparin with internally quenched fluorogenic peptides derived from heparin-binding consensus sequences, kallistatin and anti-thrombin III.Biochem J. 2002 Sep 1;366(Pt 2):435-46. doi: 10.1042/BJ20020023. Biochem J. 2002. PMID: 12000310 Free PMC article.
-
Determination of the range in binding-site densities of rat skin heparin chains with high binding affinities for antithrombin.Biochem J. 1988 Apr 1;251(1):141-5. doi: 10.1042/bj2510141. Biochem J. 1988. PMID: 3390150 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources